Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Prospective, Non-interventional Study of the Effectiveness, Safety, and Health Related Outcomes in Patients With Moderate to Severe Active Rheumatoid Arthritis Receiving Filgotinib

NCT04871919 is registered in ClinicalTrials.gov with Alfasigma S.p.A. as lead sponsor.

NCT NCT04871919
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04871919 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Prospective, Non-interventional Study of the Effectiveness, Safety, and Health Related Outcomes in Patients With Moderate to Severe Active Rheumatoid Arthritis Receiving Filgotinib
Lead sponsor
Alfasigma S.p.A.
Phase
Observational
Overall status
Active, not recruiting
Start date
May 11, 2021
Completion date
June 30, 2028
Enrollment
1,304 (actual)
Sites
89

Conditions

As the registry lists them; a condition with its own page is linked.

rheumatoid arthritis